Nurix Therapeutics
NRIX
NRIX
126 hedge funds and large institutions have $436M invested in Nurix Therapeutics in 2023 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 45 increasing their positions, 43 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.1% more ownership
Funds ownership: 89.86% → 91.97% (+2.1%)
5% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 43
Holders
126
Holding in Top 10
–
Calls
$2.21M
Puts
$225K
Top Buyers
| 1 | +$6.95M | |
| 2 | +$2.8M | |
| 3 | +$2.28M | |
| 4 |
Millennium Management
New York
|
+$1.83M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.44M |
Top Sellers
| 1 | -$3.09M | |
| 2 | -$2.18M | |
| 3 | -$2.05M | |
| 4 |
Nomura Holdings
Tokyo,
Japan
|
-$1.59M |
| 5 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
-$1.34M |